Prowess in the synthesis and delivery of therapeutics and diagnostics is a hallmark of the Chemistry of Life Processes Institute (CLP) that reflects its origins in the discovery of Lyrica® by Dr. Richard Silverman. CLP is committed to harnessing the power of transdisciplinary research among fields such as life sciences, physical sciences, engineering, and medicine to translate research into the marketplace where it can exert a profound beneficial impact on human health. CLP transdisciplinary scientists understand that interactions with the business world are critical if a new discovery is going to make it out of the lab and into the world where it can help people.
Companies Founded by CLP Faculty
Founders: Cheng Sun, Hao Zheng
Founder: Olga Volpert
Co-Founder: Jack Henkin
Founder: Thomas Meade
Founder: Thomas O’Halloran
Co-Founder: Chandler Robinson
Founder: Richard Silverman
Co-Founders: Dmitri Krainc
Founder: Jack Henkin
Co-Founders: Andrew Mazar, Olga Volpert
Northwestern Partners in Entrepreneurship
INVO catalyzes the translation of Northwestern innovations to benefit the public and promote economic growth. In order to maximize that outcome, Northwestern follows important principles when licensing university technology.
NewCures is a Northwestern initiative that focuses on accelerating biomedical research from early discovery stages to more advanced clinical stages for the benefit of the patients. The NewCures Fund aligns with existing resources to propel promising therapies towards commercialization.
Entrepreneurs-in-Residence (EIR) advise and assist faculty and students who are launching startups and commercializing IP. They are a resource for developing business concepts, making contacts with the market, connecting to investors, and forming organizational frameworks.
The CBC stimulates collaboration among researchers at Northwestern University, The University of Chicago, the University of Illinois at Chicago, and others to accelerate discovery that transforms biomedical research and improves the health of humankind.
Basic Science Discoveries Translated into Healthcare
Professor Richard Silverman (Chemistry and Molecular Biology) is not content to rest on his laurels following his extraordinary discovery of pregabalin (Lyrica®). Instead, he has used the translational resources of the Chemistry of Life Processes Institute to develop...
Nearly 40 million Americans are at risk for vision loss or blindness due to diabetes and age-related macular degeneration. Often, these diseases are diagnosed and treated much too late, after irreversible vision loss has started to occur. Hao F. Zhang (Biomedical...
Thomas O’Halloran (Chemistry and Molecular Biosciences), founding director of the Chemistry of Life Processes Institute, is responsible for the discovery of bis-choline tetra-thiomolybdate, a copper-protein binding agent that safely scavenges excess copper from the...